However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through. In the UK ...

the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

7 Hence, within the first year of treatment of osteoporosis in patients with celiac disease, the use of an antiresorptive agent to reduce bone loss is not recommended. In the described case ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...